228 Chapter 9 17. Young-Afat DA, van Gils CH, van den Bongard HJGD, et al. The Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion (UMBRELLA): objectives, design, and baseline results. Breast Cancer Res Treat 2017; 164: 445–450. 18. Utrecht COhort for Lung Cancer Outcome Reporting and Trial Inclusion (U-COLOR). ClinicalTrials.gov [Internet]. 2020; https://classic.clinicaltrials.gov/ ct2/show/NCT050. 19. Karnath HO, Sperber C, Rorden C. Mapping human brain lesions and their functional consequences. Neuroimage 2018; 165: 180–189. 20. Mampay M, Flint MS, Sheridan GK. Tumour brain: Pretreatment cognitive and affective disorders caused by peripheral cancers. British Journal of Pharmacology 2021; 178: 3977–3996. 21. Yao S, Zuo H, Li W, et al. The correlations between psychological distress, cognitive impairment and quality of life in patients with brain metastases after whole-brain radiotherapy. Clinical and Translational Oncology 2022; 25: 207–217. 22. Yaribeygi H, Panahi Y, Sahraei H, et al. The impact of stress on body function: A review. EXCLI Journal 2017; 16: 1057–1072. 23. Siassi M, Weiss M, Hohenberger W, et al. Personality rather than clinical variables determines quality of life after major colorectal surgery. Dis Colon Rectum 2009; 52: 662–668. 24. Van Der Steeg AFW, De Vries J, Roukema JA. Anxious personality and breast cancer: Possible negative impact on quality of life after breast-conserving therapy. World J Surg 2010; 34: 1453–1460. 25. Whitworth SR, Loftus AM, Skinner TC, et al. Personality affects aspects of healthrelated quality of life in parkinson’s disease via psychological coping strategies. J Parkinsons Dis 2013; 3: 45–53. 26. Koleck M, Mazaux JM, Rascle N, et al. Psycho-social factors and coping strategies as predictors of chronic evolution and quality of life in patients with low back pain: A prospective study. European Journal of Pain 2006; 10: 1. 27. Brunault P, Champagne AL, Huguet G, et al. Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patients. Psychooncology 2016; 25: 513–520. 28. Carr AJ, Gibson B, Robinson PG. Is Quality of life determined by expectations or experiences? BMJ 2001; 322: 1240–1243. 29. Kroenke CH, Kwan ML, Neugut AI, et al. Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat 2013; 139: 515–527. 30. Wolfe F. Fatigue Assessments in Rheumatoid Arthritis: Comparative Performance of Visual Analog Scales and Longer Fatigue Questionnaires in 7760 Patients, www. jrheum.org (2004). 31. Dorman S, Hayes J, Pease N. What do patients with brain metastases from nonsmall cell lung cancer want from their treatment? Palliat Med 2009; 23: 594–600. 32. Cella D, Wen PY, Ervin C, et al. Understanding the patient experience and treatment benefits in patients with non–small-cell lung cancer with brain metastasis. Cancer Med. Epub ahead of print 1 June 2023. DOI: 10.1002/ cam4.5975.
RkJQdWJsaXNoZXIy MTk4NDMw